A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Bicycle Therapeutics PLC stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 1,342 shares of BCYC stock, worth $27,376. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,342
Previous 1,072 25.19%
Holding current value
$27,376
Previous $21,000 42.86%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$19.58 - $27.24 $5,286 - $7,354
270 Added 25.19%
1,342 $30,000
Q2 2024

Jul 30, 2024

BUY
$20.02 - $24.69 $21,461 - $26,467
1,072 New
1,072 $21,000

Others Institutions Holding BCYC

About BICYCLE THERAPEUTICS plc


  • Ticker BCYC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,676,100
  • Market Cap $605M
  • Description
  • Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...
More about BCYC
Track This Portfolio

Track Mirae Asset Global Investments Co., Ltd. Portfolio

Follow Mirae Asset Global Investments Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.